Bonnie Thomas
Internal Medicine · Chicago, ILNPI 1851321467
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $24,750 of the $37,527 with a category attached, or 66.0%. Theratechnologies Inc. accounts for 67.2% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2021 at $14,042 and has fallen 77.8% since, to $3,117 in 2025. Among internal medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 559 payments — averaging $67.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Theratechnologies Inc.$25K
- Gilead$5K
- Viiv Healthcare Company$4K
- Johnson & Johnson$816
- Merck$680
- AbbVie$623
- plus $1K from 15 others
What the payments were for
- Speaking & faculty fees$24,75066%
- Travel & lodging$200%
- Food & beverage$12,75734%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Theratechnologies Inc. | 28 | $25,212 |
| Gilead | 221 | $4,886 |
| Viiv Healthcare Company | 183 | $4,190 |
| Johnson & Johnson(2 entities) | 38 | $816 |
| Merck | 28 | $680 |
| AbbVie | 19 | $623 |
| Janssen Products, LP | 2 | $208 |
| EMD Serono, Inc. | 10 | $197 |
| USWM, LLC | 9 | $194 |
| Myovant Sciences Inc. | 1 | $112 |
| Janssen Scientific Affairs, LLC | 4 | $96 |
| Indivior Inc. | 3 | $51 |
| Novo Nordisk | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Pfizer | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Exact Sciences | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| Phadia US Inc. | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $15 |
| GSK | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$37,527 in reported general payments places this provider in the 95th percentile of 5,182 internal medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 40 | $160,578 |
| DescovyEmtricitabine/Tenofov Alafenam | 18 | $41,584 |
| JardianceEmpagliflozin | 12 | $11,861 |
| BreynaBudesonide/Formoterol Fumarate | 14 | $3,017 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 50 | $1,656 |
| Alcohol Prep PadsAlcohol Antiseptic Pads | 11 | $491 |
| Ritonavir | 13 | $462 |
| Gabapentin | 28 | $353 |
| Amlodipine Besylate | 41 | $305 |
| Omeprazole | 17 | $197 |
| Tramadol Hcl | 35 | $194 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $164 |
| Pravastatin Sodium | 11 | $159 |
| Metoprolol Succinate | 20 | $142 |
| Atorvastatin Calcium | 32 | $141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $4,886 | $202,16158 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,182 internal medicine providers in Illinois.
Other internal medicine in Chicago
- Merle DiamondChicago$1.1M
- Robert KushnerChicago$516K
- Romeo UrsuaChicago$420K
- Peter O DonnellChicago$318K
- George UrbanChicago$258K
- Kristen PallokChicago$256K
- George NissanChicago$252K
- Luke LaffinChicago$162K
- Daniel CatenacciChicago$161K
- Hiren ShahChicago$144K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.